316 related articles for article (PubMed ID: 14502362)
1. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
Torres N; Mello MP; Germano CM; Elias LL; Moreira AC; Castro M
Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
[TBL] [Abstract][Full Text] [Related]
2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
3. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
4. High frequency of Q318X mutation in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in northeast Brazil.
Campos VC; Pereira RM; Torres N; Castro Md; Aguiar-Oliveira MH
Arq Bras Endocrinol Metabol; 2009 Feb; 53(1):40-6. PubMed ID: 19347184
[TBL] [Abstract][Full Text] [Related]
5. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia.
Marino R; Ramirez P; Galeano J; Perez Garrido N; Rocco C; Ciaccio M; Warman DM; Guercio G; Chaler E; Maceiras M; Bergadá I; Gryngarten M; Balbi V; Pardes E; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2011 Oct; 75(4):427-35. PubMed ID: 21609351
[TBL] [Abstract][Full Text] [Related]
6. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.
Baş F; Kayserili H; Darendeliler F; Uyguner O; Günöz H; Yüksel Apak M; Atalar F; Bundak R; Wilson RC; New MI; Wollnik B; Saka N
J Clin Res Pediatr Endocrinol; 2009; 1(3):116-28. PubMed ID: 21274396
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
8. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia.
Karaoglan M
J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1311-1320. PubMed ID: 31693496
[TBL] [Abstract][Full Text] [Related]
9. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
[TBL] [Abstract][Full Text] [Related]
11. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
Pasqualini T; Alonso G; Tomasini R; Galich AM; Buzzalino N; Fernandez C; Minutolo C; Alba L; Dain L
Medicina (B Aires); 2007; 67(3):253-61. PubMed ID: 17628913
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia.
Anastasovska V; Kocova M
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):921-6. PubMed ID: 21175091
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
14. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
15. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
16. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Madureira G; Marcondes JA; Longui CA; Leite MV; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 1998 Dec; 83(12):4416-9. PubMed ID: 9851787
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease.
Dolzan V; Stopar-Obreza M; Zerjav-Tansek M; Breskvar K; Krzisnik C; Battelino T
Eur J Endocrinol; 2003 Aug; 149(2):137-44. PubMed ID: 12887291
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis in Lebanese patients with congenital adrenal hyperplasia due to a deficit in 21-hydroxylase.
Delague V; Souraty N; Khallouf E; Tardy V; Chouery E; Halaby G; Loiselet J; Morel Y; Mégarbané A
Horm Res; 2000; 53(2):77-82. PubMed ID: 10971093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
